Conversations in Clinical Trial Readiness
Helping Sites and Teams Make the Shift to Decentralized Trials with Paul Evans
Episode Summary
Paul Evans of Velocity Clinical Research joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss best practices for sites making the shift toward decentralized trials. He shares how his own organization was able to pivot so quickly when the pandemic hit, why it’s too early to make the call on whether virtual will be cost saving, and how he pictures the future of his 12 (and counting) sites.
Episode Notes
Topics covered and questions you’ll uncover during this episode:
- Why brick-and-mortar and virtual constitute a continuum, not a dichotomy.
- What teams need to do to be successful transitioning to virtual.
- Why remote monitoring still poses a challenge.
- Why tech isn’t always optimized for the site side.
- How remote improves patient engagement and retention.
- Why the clinical research coordinator role is changing, right down to the essential skillsets.
- What we need to do to make sure site coordinators are comfortable enough to be effective with the tech they need to adopt.
- Why we’re probably a long way from seeing virtual as a money-saver, and what will need to change to make it cost-effective.
- How lessons learned in the late 90’s can be an instructive cautionary tale today.
Resources mentioned within episode: